1,2,9-Nonanetriol>97.0%(GC)5g

(R)-1-tert-Butyl 2-methyl 4-oxopyrrolidine-1,2-dicarboxylate, 95.0%, 100mg

(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

[(1,3-Dioxoisoindolin-2-yl)methyl] methylcyanocarbonimidodithioate, 250mg

(S)-2-Amino-2-(2-bromo-4-fluorophenyl)acetic acid hydrochloride, 98%, 1g

5-(3,5-dimethyl-4-methoxyphenyl)-5-oxovaleric acid, 97.0%, 1g

methyl 2-{[2-({[(tert-butoxy)carbonyl]amino}methanimidoyl)-1-benzothiophen-4-yl]oxy}-2-phenylacetate, 99%, 10mg

1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, 95%, 25g

2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 1g

4-Chloro-3-formylbenzonitrile, 95.0%, 5g

5-Methylindoline-2,3-dione, 97.0%, 1g

7-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 1g

2-Fluoro-5-nitrobenzaldehyde>98.0%(GC)5g